Cognition Therapeutics (CGTX) Earnings Date & Reports

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CGTX is expected to report earnings to fall 40.38% to -11 cents per share on May 07

Cognition Therapeutics CGTX Stock Earnings Reports

Q1'25

Est.

$-0.11

Q4'24

Missed

by $0.02

Q3'24

Missed

by $0.05

Q2'24

Beat

by $0.06

Q1'24

Missed

by $0.02

The last earnings report on March 20 showed earnings per share of -18 cents, missing the estimate of -17 cents. With 677.85K shares outstanding, the current market capitalization sits at 23.37M.

View a ticker or compare two or three

Compare

CGTX